Back to today’s briefing

Story perspectives

Patients Sue Ozempic Over Alarming Vision Loss Risk

5/20/2025

44 9

Summary

Story summary

Patients taking Ozempic for diabetes and weight loss are facing alarming side effects, including irreversible vision loss. Edward Fanelli, the first to file a lawsuit in New Jersey, alleges he was never informed of this risk. His attorney is advocating for updated warnings and compensation for affected clients, while Novo Nordisk insists that such vision issues are rare and unrelated to the medication.

1 of 1

Story summary

Patients taking Ozempic for diabetes and weight loss are facing alarming side effects, including irreversible vision loss. Edward Fanelli, the first to file a lawsuit in New Jersey, alleges he was never informed of this risk. His attorney is advocating for updated warnings and compensation for affected clients, while Novo Nordisk insists that such vision issues are rare and unrelated to the medication.